Investigators from Weill Cornell Medicine have discovered a defense mechanism that protects skin cancer cells from oxidative stress and helps them spread.
A gift totaling $25 million from Irwin M. Jacobs ’54, BEE ’56 and the Jacobs family includes a new $15 million commitment, adding to a $10 million commitment in 2023 that helped establish the center.
A preclinical trial has identified a way to thwart the highly addictive nature of opioids such as morphine and oxycodone while maintaining the drugs’ ability to relieve pain.
The findings could lead to new treatments targeting a particular protein to better manage inflammation in patients who don’t respond well to existing therapies.
The College of Veterinary Medicine and partners have launched a free online course, “Mental Health and Suicide Prevention in Rural America,” to give learners support strategies and resources to navigate mental health challenges in rural communities.
Cornell researchers develop affordable test for iron deficiency, which affects 2 billion people, disproportionately impacting women of childbearing age as well as infants and young children.
A new study emphasizes the importance of considering sex differences in Alzheimer’s research – a step that could ultimately lead to more precise and effective treatments.
A new technology enables the control of specific brain circuits non-invasively with magnetic fields, according to a preclinical study from researchers at Weill Cornell Medicine, the Rockefeller University and the Icahn School of Medicine at Mount Sinai.